Furthermore, the review explores novel drug delivery strategies, such as microsphere encapsulation, injectable hydrogels, Fc-fusion, and oral small-molecule formulations, aimed at achieving sustained and controlled release to reduce dosing frequency and improve patient compliance
Oral GLP-1 Formulations and Future Projections Several companies are developing oral GLP-1 formulations, including Novo Nordisk, Pfizer, and smaller firms, positioning them as potential acquisition targets
The choice between medications should consider individual tolerance, weight loss efficacy, and other factors
Huang Y, Wang X, Li W, Yue F, Wang M, Zhou F
Didn't take long for these to shoot to the top after approval, Bryce Platt, PharmD
These growing cases and raised efficacy with enhanced glycemic control and weight loss make them a preferred treatment option for many patients